Effect of BRCA1/2 Status on Response to Neoadjuvant Carboplatin in TNBC
17.08.2017
Unser Paper zur Mutationsanalyse im Geparsixto-TNBC-Arm wurde in den ASCO-News besprochen.
Effect of BRCA1/2 Status on Response to Neoadjuvant Carboplatin in Triple-Negative Breast Cancer.
News
-
28.09.2023 Translational Work from GeparSepto published
The prognostic and predictive potential of CAV1/2 expression was analysed in the GeparSepto trial (GBG 069).
Mehr ... -
27.09.2023 GBG research at SABCS
GBG will present several posters at the San Antonio Breast Cancer Symposium 2023
Mehr ... -
21.09.2023 New review on Immune Cell Infiltration published
A review from the International Immuno-Oncology Biomarker Working about tumor immunology was published in the journal of pathology.
Mehr ... -
07.09.2023 Save the date! GBG Annual Scientific Meeting 2024
Das 21. Annual Scientific Meeting 2024 wird am 29.2. bis 1.3. in Frankfurt stattfinden.
Mehr ...